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Edited by Shou-Wei DingAbstract We performed genome wide gene expression analysis
on L4 stage Caenorhabditis elegans rrf-3(pk1426) and eri-
1(mg366) mutant strains to study the eﬀects caused by loss of
their encoded proteins, which are required for the accumulation
of endogenous secondary siRNAs. Mutant rrf-3 and eri-1 strains
exhibited 72 transcripts that were co-over-expressed and 4 tran-
scripts co-under-expressed (>2-fold, P < 0.05) compared to N2
wild type strain. Ontology analysis indicated these transcripts
were over represented for protein phosphorylation and sperm
function genes. These results provide additional support for the
hypothesis that RRF-3 and ERI-1 act together in the endo-si-
RNA pathway, and furthermore suggests their involvement in
additional biological processes.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Gene silencing through RNA interference (RNAi) pathways
are mediated by small RNAs of 21–24 nt in length found in
virtually all eukaryotes [1,2]. This evolutionary conserved
mechanism has likely evolved to protect organisms against
invading exogenous nucleic acids but its endogenous roles
are only beginning to be better understood [3–6]. Studies on
Caenorhabditis elegans have revealed a wide variety of micro-
RNAs (miRNAs) and endogenous small interfering RNAs
(endo-siRNAs) with an apparent regulatory role for animal
health and development [2,6–8].
In C. elegans, miRNAs enter their own pathway, while si-
RNAs enter speciﬁc pathways depending on the origin and
molecular structure of the initial trigger molecule and speciﬁc
downstream processing enzymes. The pathways for exogenous
siRNA (exo-siRNA) and endogenous siRNA (endo-siRNA)
uses in part, separate enzymes while sharing others including
dicer (DCR-1) [7,8]. siRNA ampliﬁcation has been shown to
use alternative RNA-dependent RNA polymerases (RdRPs)
for synthesis of secondary siRNAs to produce RNAi eﬀects
[7–9]. According to current models, the endo-siRNAs pathway
uses the RdRP homolog RRF-3, while the exo-siRNA path-*Corresponding author. Address: Department of Biosciences, Kuopio
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doi:10.1016/j.febslet.2007.09.043way uses RRF-1 [7,8]. Germ cells use a third RdRP homolog,
EGO-1, for exo-siRNAs [7,8,10].
RRF-3 associates, in a large complex, physically with ERI-1,
a conserved protein with DEDDh-like exonuclease and SAP/
SAF-box nucleic acid binding domains in the endo-siRNA
pathway [8,11]. Both of these proteins are required for accu-
mulation of at least some endo-siRNAs [7,8]. Both mutants
are sterile in 25 C, exhibit high incidence of males (Him-
phenotype) due to X-chromosome non-disjunction, and are
hypersensitive to exogenous RNAi (enhanced RNAi, ERI-
phenotype) [11,12]. The enhanced sensitivity to exogenous
RNAi has been exploited in a number of whole genome RNAi
screens and has thus led to widespread use of both rrf-3 (RNA-
dependent RNA polymerase-3) and eri-1 (enhanced RNAi-1)
mutants in gene silencing experiments [13]. It has been pro-
posed that the ERI-phenotype is caused by release of limiting
components from the endogenous to the exogenous RNAi
pathway in these mutants [7,8].
Genome wide gene expression analysis was performed on C.
elegans rrf-3 and eri-1 mutant strains to study transcriptional
eﬀects caused by loss of their encoded proteins in the endoge-
nous RNAi pathway and to provide further insight into their
functions. Mutant strains exhibited highly similar expression
patterns and co-regulation of over-expressed transcripts was
observed for genes encoding proteins associated with protein
phosphorylation and sperm function. These results provide
additional support for the model where RRF-3 and ERI-1
act in the same pathway, and suggests that they aﬀect addi-
tional biological functions.2. Materials and methods
2.1. Sample preparations
rrf-3(pk1426) mutant worms (NL2099), eri-1(mg366) mutant worms
(GR1373), and wild type worms (N2) were grown on culturing plates
containing NGM agar media with OP50 Escherichia coli (E. coli) as a
food source [14]. Animals were synchronized by hatching puriﬁed eggs
using 1% hypochlorite solution with 250 mM KOH. Worms were
grown at 20 C and harvested at the fourth larval (L4) stage. RNA iso-
lation was made using Ribopure Total RNA isolation-kit (Ambion,
Foster City, CA). Animals were grown separately and RNA isolated
separately for each biological replicate (three for microarrays, three
for quantitative real-time PCR). RNA samples were isolated separately
for microarray, qRT-PCR, and Northern blot experiments. Worm
stains were genotyped by PCR to conﬁrm their identities (data not
shown).
2.2. Microarray analysis
Puriﬁed total RNA was labeled for chip experiments using One cycle
cDNA synthesis followed by cRNA synthesis according to the manu-
facturer’s protocol (Aﬀymetrix, Palo Alto, CA). cRNA from eachblished by Elsevier B.V. All rights reserved.
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Fig. 1. Venn-diagram of >2-fold over-expressed (A) and under-
expressed genes (B) in rrf-3(pk1426) and eri-1(mg366) mutants
compared to N2.
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containing 22500 transcripts (Aﬀymetrix) as three biological replicates
(3 chips each for N2, rrf-3, eri-1). Microarray hybridization and scan-
ning was performed at the Biomedicum Biochip Core Facility (Hel-
sinki, Finland). GeneSpring-software (Agilent, Palo Alto, CA) was
used to carry out data-analysis. For the probe intensity values gener-
ated by the Aﬀymetrix scanner, Robust Multichip Average (RMA) –
algorithm was used for normalization and statistical processing. Data
were then ﬁltered to remove genes with low expression values (<10). T-
test was performed to sequentially ﬁlter out genes with unreliable sig-
nal level between replicates (P < 0.05) and then to collect genes with
signiﬁcant signal level between samples (P < 0.05). Finally, genes were
ﬁltered for fold change (>2-fold up or <0.5-fold down).
2.3. Functional analysis
Annotations for the regulated genes were obtained from Aﬀymetrix
and supplemented with additional annotations from David 2.1 [15]. In
the case that no known annotations existed, manual annotations were
extracted fromWormbase. Lists of up- and down-regulated genes were
uploaded to David 2.1. Calculations of overrepresented GO biological
process annotations using functional annotation clustering was per-
formed using the GOchart function. Signiﬁcance cutoﬀ was set at
P < 0.05.
2.4. Quantitative real-time PCR (qRT-PCR) and Northern blot
qRT-PCR was performed using Power SYBR Green PCR kit (Ap-
plied Biosystems, Foster City, CA) according to the manufacturers
instructions. Ampliﬁcations were performed on ABI Prism 7700 (Ap-
plied Biosystems). Act-1 was used as a control to normalize transcript
levels. PCRprimers designed by Primer 3 [16] were as follows: act-1 (left,
5 0tcggtatgggacagaaggac, right 5 0catcccagttggtgacgata); ssp-16 (left,
5 0ttaacggaggtgccgataag, right, 5 0 tttgtcctcctttggtgctc); T16G12.7 (left,
5 0tatggagcaaagggtggaac, right, 5 0ccagagcagtgtacggcata); C35E7.9 (left,
5 0gatggattctcgctggatgt; right, 5 0attctccacaggcggtttc); F25B3.4, (left,
5 0ctgacacgtcttattccacctg, right, 5 0gtgagttgacctcaatgagca); clec-69, (left,
5 0tggtggtgacagttcagagc; right, 5 0agctggaagattggttgtgc). For the north-
ern blot, an antisense probe for ssp-16 transcript (ssp-16: 5 0TGGTGC-
GAAATGAACGACAAGTTTGTCCTCCTTTG) and (act-1: 5 0GG-
TGGTTCCTCCGGAAAGAACAGTGTTGGCGTACA)was labeled
with a-[33P]-dATP using terminal deoxytransferase, and hybridized to
Northern blots containing total RNA (10 lg per lane) isolated from
each strain. Northern blots were hybridized overnight at 42 C in
5· SSPE, 50% formamide, 5·Denhardt’s solution, 10% dextran sulfate,
1% SDS, and washed thrice at room temperature for 2 min in 4· SSC,
0.1% SDS, and thrice at room temperature for 1–2 min in 0.2· SSC,
0.1% SDS until there was no longer background signal, dried, and
exposed on a phosphor screen overnight.3. Results
3.1. Microarray and GO analysis
All microarray data used in this experiment is available in
MIAME format at GEO database (www.ncbi.nih.gov/geo)
(Accession: GSE8659). In the rrf-3mutant, we observed a total
of 112 over- and 17 under-expressed genes, while in the eri-1
mutant, 199 over- and 66 under-expressed genes were found
(Fig. 1). An overlap of 72 over- and 4 under-expressed genes
were identiﬁed. The list of overlapping over-expressed genes
is shown in Table 1. Twenty-ﬁve co-over-expressed genes
matched previously cloned siRNAs. Complete gene lists
are shown in supplementary material Table S1 (available
at http://www.uku.ﬁ/aivi/neuro/genomics/rrf-3.shtml). Gene
ontology analysis was performed with DAVID 2.1 using
Aﬀymetrix probe set identiﬁers to calculate statistically
enriched GO (gene ontology) molecular function annotations
for the overlapping over-expressed genes (Table 2). Complete
GO annotations (molecular function, biological process, and
cellular component) for all regulated gene lists are availablein Table S2 (available at http://www.uku.ﬁ/aivi/neuro/genom-
ics/rrf-3.shtml). From the list of overlapping genes, we ob-
served a statistically signiﬁcant enrichment of both protein
tyrosine (P < 104) and serine/threonine kinases (P < 1011).
From the list of down regulated genes, signiﬁcant enrichment
(P < 0.01) of oviposition and reproductive behavior were ob-
served in rrf-3 mutants and sugar/carbohydrate binding
(P < 0.05) in eri-1 mutants.
3.2. Conﬁrmation with quantitative RT-PCR
Five genes were selected for conﬁrmation by quantitative
RT-PCR. These genes were chosen based on magnitude of
change and common over-expression in rrf-3 and eri-1 mu-
tants, and representing sperm speciﬁc proteins, phosphatases,
and a lectin type protein. Act-1 was used as a control. The
microarray changes correlated well with the qRT-PCR,
although the magnitudes of the changes were not always iden-
tical (Table 3). We also performed Northern blot analysis on
ssp-16 using act-1 as a loading control and obtained results
similar to those from qRT-PCR (Fig. 2).4. Discussion
Recent studies indicate that RRF-3, an RNA-dependent
RNA polymerase, and ERI-1, a conserved exonuclease are re-
quired for accumulation of endogenous siRNAs. Both proteins
are physically linked in a complex with DCR-1 [7,8,17], and
mutants share identical enhanced RNAi (ERI) phenotypes.
To study gene expression eﬀects caused by loss of these pro-
Table 1
List of 72 commonly over-expressed genes in rrf-3(pk1426) and eri-1(mg366) mutants vs. N2
Wormbase gene Fold change rrf-3 vs. N2 Fold change eri-1 vs. N2 Annotation
Y106G6G.3 9.39 8.43 Dynein light chain motif
F59A6.2 7.49 5.57
Y39E4B.11 7.02 5.74
Y54G11A.13 6.13 6.83 ctl-3, catalase
T27A3.3* 5.93 6.38 ssp-16, sperm-speciﬁc class P protein 16
T16G12.7* 5.61 5.71 Protein phosphatase 1
W08E3.4 5.14 4.53
ZK666.8 4.54 4.02 Serine/threonine kinase
F25B3.4* 4.54 4.52 Serine/threonine protein phosphatase
C38C10.3 4.52 3.88
T01C3.5 4.51 4.23
Y54G11A.6 4.47 5.01 ctl-1, catalase
F09C12.8* 4.35 3.68 Phosphoglyserate mutase motif
Y6E2A.9 4.28 3.00 Proton or iron transport? Sideroﬂexin?
F47B3.5* 4.27 3.96
Y38H6C.15 4.24 3.40
F09G8.4 4.11 3.95 ncr-2, homolog of human NPC1, which when mutated
leads to Niemann-Pick disease
B0218.5 4.07 3.88 Kinase activity
C35E7.9* 3.88 4.09 H5 and major sperm protein domain protein
C25A8.5 3.88 3.84 Protein-tyrosine kinase
K07F5.6* 3.77 3.84 Protein-tyrosine phosphatase
ZC581.7* 3.69 3.35 Protein-tyrosine kinase
Y53F4B.45 3.66 3.90
ZK1010.5* 3.53 3.48
ZK484.7 3.49 3.17 Protein-tyrosine phosphatase
C49C8.1* 3.48 2.81 Serine/threonine kinase
C54G4.3* 3.46 3.39
F58D5.7 3.38 3.22
C47A4.5 3.37 3.30
C05C12.1 3.30 3.14 Serine/threonine kinase
C10C6.3 3.27 2.28
C33F10.8* 3.19 3.41 Protein-tyrosine phosphatase
F53C3.1 3.10 3.01 protein kinase
K07F5.4 3.07 2.86 kin-24, protein KINase family member
R05H5.4* 3.05 2.52 Tyrosine-protein kinase (FES/FPS subfamily)
ZC168.6 3.04 3.01 Sperm-speciﬁc protein
ZK507.1 3.03 3.92 Serine/threonine-protein kinase
F02C9.4 3.01 2.98 Protein-tyrosine kinase, EGF receptor activity
ZK973.8* 3.00 2.59
C29E6.3* 2.99 3.09 pph-2, Protein PHosphatase family member
W03C9.1* 2.92 2.51
F56F3.4 2.90 2.48 Ubiquitin family
ZC412.5* 2.86 2.61
F54C8.1 2.82 2.78 Probable 3-hydroxyacyl-CoA dehydrogenase
F26F4.2 2.82 2.75 spt-2, novel protein with high similarity to C. elegans F37A8.1
W01B6.2 2.79 3.19 Serine/threonine kinase
F07F6.1 2.73 3.21 Nucleotide binding
ZK354.6 2.73 2.60 Protein kinase
F11G11.8* 2.71 2.06 nspd-4//nspd-5
F54A3.4 2.68 3.58 Homolog of the human gene CBS, which when mutated
leads to homocystinuria
C24D10.1 2.68 2.54 Protein-tyrosine phosphatase
K01D12.15* 2.68 3.02
F58D2.2 2.67 2.92
Y71F9AL.2 2.62 2.78 Protein kinase
F59A3.8 2.58 2.88 Protein kinase
E03H12.7 2.55 2.82
C39H7.1 2.47 2.26 Casein kinase, serine/threonine kinase
C04G2.8* 2.43 2.38
F31E8.5 2.38 2.26
C25G4.6* 2.34 2.56 PDZ domain (also known as DHR or GLGF)
C41H7.6 2.33 2.10
ZK637.12 2.28 2.05
C25G4.4 2.24 2.05 tag-347, SAND domain
T22B3.2 2.21 2.81
F13G11.2 2.20 2.13
F56A11.6* 2.16 2.06
C24D10.7* 2.14 2.03
Y38H8A.4 2.13 2.17 Serine/threonine kinase
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Table 1 (continued)
Wormbase gene Fold change rrf-3 vs. N2 Fold change eri-1 vs. N2 Annotation
B0205.10* 2.11 2.42
C34F11.1 2.05 2.17 Protein and zinc ion binding
T21G5.4* 2.00 2.16 Protein binding
Y95B8A.4 2.00 2.20
Values for fold change are the average from 3 independent biological replicates. Annotations were provided by Aﬀymetrix when available and were
supplemented manually by Wormbase and DAVID 2.1 gene ontologies. *, indicates match with cloned siRNA [7,20].
Table 2
Over-represented Gene Ontology (GO) molecular function terms associated with co-over-expressed gene list from rrf-3 and eri-1 mutant animals
GO term (molecular function) Count % P-value
Protein kinase activity 17 22.08 3.43E11
Phosphotransferase activity, alcohol group as acceptor 17 22.08 1.59E10
Kinase activity 17 22.08 3.65E10
Transferase activity, transferring phosphorus-containing groups 17 22.08 5.21E09
Catalytic activity 32 41.56 5.32E08
ATP binding 16 20.78 1.49E07
Adenyl nucleotide binding 16 20.78 2.31E07
Phosphoprotein phosphatase activity 9 11.69 2.64E07
Nucleotide binding 17 22.08 1.53E06
Purine nucleotide binding 16 20.78 1.57E06
Phosphoric monoester hydrolase activity 9 11.69 1.69E06
Phosphoric ester hydrolase activity 9 11.69 4.18E06
Transferase activity 17 22.08 1.20E05
Protein tyrosine phosphatase activity 6 7.79 6.81E05
Protein-tyrosine kinase activity 7 9.09 1.48E04
Protein serine/threonine kinase activity 7 9.09 2.56E04
Hydrolase activity, acting on ester bonds 9 11.69 5.05E04
GO term annotations were assigned and statistically evaluated using David 2.1. The count indicates the number of observations from the input of the
72 genes. Terms are listed in decreasing order of signiﬁcance (P-value).
Table 3
Comparison of microarray and quantitative real-time PCR (qRT-PCR) results
Gene Annotation Microarray rrf-3(pk1426) qRT-PCR Microarray eri-1(mg366) qRT-PCR
T27A3.3 Sperm-speciﬁc class P protein 16 (ssp-16) 5.9 12.5 ± 4.5 6.4 10.3 ± 5.5
T16G12.7 Protein phosphatase 1 5.6 8.9 ± 1.6 5.7 5.3 ± 1.5
C35E7.9 Sperm speciﬁc domain protein 3.8 5.7 ± 1.7 4.1 3.6 ± 0.9
F25B3.4 ser/thr protein phosphatase 4.5 4.9 ± 1.3 4.5 3.1 ± 1.7
F56D6.15 c-type lectin family member (clec-69) Non-regulated 0.7 ± 0.9 0.2 0.19 ± 0.07
Values shown are normalized ratios ±S.D. from 3 biological replicates comparing N2 and rrf-3(pk1426) and eri-1(mg366) strains. Independent
biological replicates were used for microarray and qRT-PCR experiments.
ssp-16
actin
N2 rrf-3         eri-1
Fig. 2. Northern blot was performed to evaluate expression levels of
the ssp-16 gene. Total RNA (10 lg) from the indicated wild type (N2)
or mutant strains (rrf-3(pk1426), eri-1(mg366)) was isolated, and
probes were prepared, hybridized, and exposed as described in Section
2. Act-1 was used as a control. Estimated sizes for the bands were
0.5 kb (ssp-16) and 2.0 kb (act-1).
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mutant C. elegans strains.
We observed relatively uniform gene expression patterns
with a large amount of shared over-expressed genes in L4 stagerrf-3 and eri-1 mutants, suggesting a common biological func-
tion. Tyrosine and threonine/serine protein phosphatases and
kinases were shown to be over-represented in genes at least
2-fold over-expressed in the mutants. This suggests a novel role
for posttranslational protein modiﬁcations. The targets of
these phosphatases and kinases have yet to be identiﬁed and
could be within the endo-siRNA pathway or elsewhere. Sec-
ondary siRNAs are known to be triphosphorylated at the 5 0
ribose moiety distinguishing them from DCR-1 processed pri-
mary siRNAs with 5 0 monophosphates, indicating the impor-
tance of phosphorylation status in siRNA function [18,19].
Both strains share at least three over-expressed genes that
are sperm speciﬁc and is consistent with the sperm defective
high temperature sterility of these mutants [8,12]. Among the
commonly over-expressed transcripts were three genes with
Major Sperm Protein (MSP)-domain (ssp-16, C35E7.9 and
ZC168.6). While the study here was performed on L4 worms
raised at 20 C, some germ or sperm cell perturbation may oc-
5054 S. Asikainen et al. / FEBS Letters 581 (2007) 5050–5054cur despite their superﬁcially wild type appearance. This can be
under consideration when using these strains for RNAi screens
[13].
Loss of key endo-siRNA pathway proteins causes up-regula-
tion of target mRNAs, likely due to the loss of complementary
siRNA production [7,8,20]. Our results appear to support this
notion, since at least 25 genes that were increased in rrf-3 and
eri-1 vs. N2 have been cloned as endo-siRNAs [7,20]. This
number is likely to be an underestimation and could increase
when more endo-siRNAs are cloned and annotated. Alterna-
tively, over-expression could occur through indirect non-siR-
NA mediated mechanisms.
While this manuscript was in preparation Lee et al. [7]
reported the expression proﬁling of mixed stage population
rrf-3 and eri-1 mutants along with several additional RNAi
pathway related proteins. Comparison of 2-fold elevated tran-
scripts revealed only a few matches between their and our
study (rrf-3, 6/112; eri-1, 1/199; data not shown). The small
number of common over-expressed genes from the previous
and current study suggests large diﬀerences in gene expression
in these strains that depend upon the developmental stage.
Our results suggest that the majority of gene expression lev-
els are not signiﬁcantly changed in rrf-3 and eri-1 mutant
strains. Future RNAi screening studies can likely be performed
with these strains without major concern for background
eﬀects. Co-regulation of a large number of genes provides
supporting evidence that RRF-3 and ERI-1 function together,
likely in the endo-siRNA pathway. Finally, our data suggests
their novel involvement in additional biological processes
including protein phosphorylation.
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